Phase II Trial of Weekly Nab-Paclitaxel for Previously Treated Advanced Non-Small Cell Lung Cancer: KTOSG Trial 1301

被引：0
|
作者：
Sakata, Shinya [1 ]
Saeki, Sho [1 ]
Okamoto, Isamu [2 ]
Otsubo, Kohei [2 ]
Komiya, Kazutoshi [3 ]
Morinaga, Ryotaro [4 ]
Yoneshima, Yasuto [2 ]
Koga, Yuichiro [2 ]
Enokizu, Aimi [2 ]
Kishi, Hiroto [5 ]
Hirosako, Susumu [1 ]
Yamaguchi, Emi [1 ]
Aragane, Naoko [3 ]
Fujii, Shinji [6 ]
Harada, Taishi [2 ]
Iwama, Eiji [2 ]
Nakanishi, Yoichi [2 ]
Kohrogi, Hirotsugu [1 ]
机构：
[1] Kumamoto Univ Hosp, Dept Resp Med, Kumamoto, Japan
[2] Kyushu Univ, Grad Sch Med Sci, Res Inst Dis Chest, Fukuoka, Japan
[3] Saga Univ, Saga, Japan
[4] Oita Prefectural Hosp, Dept Resp Med & Oncol, Oita, Japan
[5] Kumamoto City Hosp, Dept Resp Med, Kumamoto, Japan
[6] Kumamoto Reg Med Ctr, Div Resp Dis, Kumamoto, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
non-small cell lung cancer; objective response rate; nab-paclitaxel; phase II trial;
D O I：
10.1016/j.jtho.2016.11.1266
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.03a-056
引用
收藏
页码：S923 / S923
页数：1
相关论文
共 50 条
  • [21] Nab-Paclitaxel for Previously Treated Advanced Non-Small Cell Lung Cancer: Analysis of Safety and Efficacy for Patients With Renal Impairment
    Yoneshima, Yasuto
    Morita, Satoshi
    Ando, Masahiko
    Nakamura, Atsushi
    Iwasawa, Shunichiro
    Yoshioka, Hiroshige
    Goto, Yasuhiro
    Takeshita, Masafumi
    Harada, Toshiyuki
    Hirano, Katsuya
    Oguri, Tetsuya
    Kondo, Masashi
    Miura, Satoru
    Hosomi, Yukio
    Kato, Terufumi
    Kubo, Toshio
    Kishimoto, Junji
    Yamamoto, Nobuyuki
    Nakanishi, Yoichi
    Okamoto, Isamu
    CLINICAL LUNG CANCER, 2022, 23 (07) : 585 - 592
  • [22] Phase I/II Trial of Carboplatin, nab-Paclitaxel and Bevacizumab for Advanced Non-Squamous Non-Small Cell Lung Cancer: Results of Phase I Part
    Ikeo, Satoshi
    Nogami, Naoyuki
    Kitajima, Hiromoto
    Yoshioka, Hiroshige
    Bessho, Akihiro
    Kaira, Kyoichi
    Kubo, Toshio
    Murakami, Shuji
    Watanabe, Koshiro
    Kiura, Katsuyuki
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S905 - S905
  • [23] A phase II trial of weekly paclitaxel and carboplatin for elderly patients with advanced non-small cell lung cancer (NSCLC).
    Usui, K
    Inoue, A
    Ishimoto, O
    Tanaka, M
    Koinumaru, S
    Matsubara, N
    Kanbe, M
    Gomi, K
    Saijo, Y
    Nukiwa, T
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 682S - 682S
  • [24] Phase II trial of weekly paclitaxel and concurrent radiation therapy for locally advanced non-small cell lung cancer
    Choy, H
    Safran, H
    Akerley, W
    Graziano, SL
    Bogart, JA
    Cole, BF
    CLINICAL CANCER RESEARCH, 1998, 4 (08) : 1931 - 1936
  • [25] Standard versus low-dose nab-paclitaxel in previously treated patients with advanced non-small cell lung cancer: A randomized phase II trial (JMTO LC14-01)
    Takeuchi, Susumu
    Kubota, Kaoru
    Sugawara, Shunichi
    Teramukai, Satoshi
    Noro, Rintaro
    Fujikawa, Kei
    Hirose, Takashi
    Atagi, Shinji
    Minami, Seigo
    Iida, Shinichiro
    Kuraishi, Hiroshi
    Aiba, Tomoiki
    Minegishi, Yuji
    Matsumoto, Masaru
    Seike, Masahiro
    Gemma, Akihiko
    Kawahara, Masaaki
    CANCER MEDICINE, 2023, 12 (08): : 9133 - 9143
  • [26] A Phase II Trial of Denileukin Diftitox in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer
    Gerena-Lewis, Margie
    Crawford, Jeffrey
    Bonomi, Philip
    Maddox, Ann Marie
    Hainsworth, John
    McCune, David E.
    Shukla, Rakesh
    Zeigler, Haoyue
    Hurtubise, Paul
    Chowdhury, Tracy R.
    Fletcher, Brandon
    Dyehouse, Karyn
    Ghalie, Richard
    Jazieh, Abdul R.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009, 32 (03): : 269 - 273
  • [27] nab-Paclitaxel/carboplatin in elderly patients with advanced squamous non-small cell lung cancer: a retrospective analysis of a Phase III trial
    Gridelli, Cesare
    Chen, Tianlei
    Ko, Amy
    O'Brien, Mary E.
    Ong, Teng Jin
    Socinski, Mark A.
    Postmus, Pieter E.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 : 1445 - 1451
  • [28] Phase II trial of gemcitabine and weekly cisplatin for advanced non-small cell lung cancer
    Shepherd, FA
    Cormier, Y
    Burkes, R
    Evans, WK
    Goss, G
    Klimo, P
    Feld, R
    Taylor, M
    SEMINARS IN ONCOLOGY, 1997, 24 (03) : 827 - 830
  • [29] Phase II trial of weekly paclitaxel in patients with previously treated advanced urothelial cancer
    Vaughn, DJ
    Broome, CM
    Hussain, M
    Gutheil, JC
    Markowitz, AB
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (04) : 937 - 940
  • [30] Phase I/II trial of paclitaxel and vinorelbine in advanced non-small cell lung cancer
    Grunberg, SM
    Dugan, MC
    Greenblatt, MS
    Ospina, DJ
    Valentine, JW
    CANCER INVESTIGATION, 2005, 23 (05) : 392 - 398
12345